NCT00446901 Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene Expression Status COMPLETED Phase NA
NCT00444639 Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT) Status TERMINATED Phase PHASE2
NCT00442000 Outcomes Comparison of Robotic, Retropubic, and Perineal Prostatectomy Status COMPLETED Phase N/A
NCT00441532 Study On Lidocaine Vs. Placebo Pain Control During Transrectal Ultrasound Guided Prostate Biopsy Status COMPLETED Phase NA
NCT00441337 A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies Status COMPLETED Phase PHASE1
NCT00439751 Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy Status COMPLETED Phase PHASE3
NCT00433797 Dietary Intervention With Phytochemicals and Polyunsaturated Fatty Acids in Prostate Cancer Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00433602 Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors Status COMPLETED Phase N/A
NCT00433446 S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy Status COMPLETED Phase PHASE2
NCT00433407 T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors Status COMPLETED Phase NA
NCT00430183 Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT00429338 3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate Status TERMINATED Phase NA
NCT00428714 Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy Status COMPLETED Phase PHASE2
NCT00427999 Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT00426777 Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer Status COMPLETED Phase PHASE3